Post-Authorisation Safety Study (PASS) of the Utilisation Patterns of Apixaban in Denmark

16/08/2016
01/04/2024
EU PAS number:
EUPAS14786
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.24 MB - PDF) View document
Study results
Study report
Study report
English (1.39 MB - PDF) View document
Other information
Publications